Navigation Links
DNA Medicine Institute Awarded Two Phase III SBIR NASA Contracts for Its rHEALTH Sensor
Date:6/29/2011

CAMBRIDGE, Mass., June 29, 2011 /PRNewswire/ -- In September 2010, the DNA Medicine Institute (DMI) successfully completed reduced-gravity experiments on its rHEALTH sensor for the NASA Facilitated Access to the Space Environment for Technology (FAST) program.  NASA recently followed that experiment with a $190,000 contract to DMI to analyze data from the parabolic flights.

According to DMI's Chief Scientific Officer Eugene Y. Chan, the reduced gravity experiments "yielded [fantastic] data, which will aid DMI in developing our rHEALTH sensor for use as a universal biomedical laboratory in future space environments."

Based on DMI's successful work under a pair of Phase II Small Business Innovation Research Program contracts designed to develop nanoscale diagnostic technologies that facilitate whole health analysis in a single drop of blood, DMI's rHEALTH sensor has been identified by NASA as a viable approach for performing blood and urine analysis on the International Space Station. Rather than relying on ground-based analysis, NASA is promoting the development of the rHEALTH sensor to provide on-orbit analysis capabilities.  The device will directly impact all biomedical research on ISS, and it may also play a critical role in medical and environmental monitoring.  

A second contract, Universal In-Flight Health Diagnostic Technology -- this one in the amount of $420,000 -- was also recently awarded to DMI, to perform clinical validation on white blood cells.  The goal of the contract will be to develop the capabilities to validate the sensor's white blood cell counts, from fingerstick human blood samples, against a recognized medical standard. This award will be funded by HHC (NASA Human Health and Countermeasures) and administered by the NASA Glenn Research Center.

The rHEALTH sensor also has significant dual-use terrestrial applications, such as real-time health monitoring at a patient's bedside or in a doctor's office, allowing for critical clinical interventions in acute situations.

About the DNA Medicine Institute

DMI utilizes an interdisciplinary, multi-faceted approach to innovation that draws upon diverse and disparate fields including medicine, nanotechnology, genomics, biophysics, biochemistry, molecular biology, and advanced engineering. Its core beliefs are that successful, innovative commercial products can make a long-lasting impact on patient care. It currently does research on intuitive medical devices, smartly designed drugs, and powerful research instrumentation. For more information, visit: www.dnamedinstitute.com.


'/>"/>
SOURCE DNA Medicine Institute
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. New Phase 2 Data Published in New England Journal of Medicine Show Bardoxolone Methyl Sustained Improvement in Measure of Kidney Function (eGFR) Over 52 Weeks in Patients With Moderate to Severe Chronic Kidney Disease and Type 2 Diabetes
2. aTyr Pharma Honored with Red Herring 100 North America Award for Discovering and Developing Innovative Medicines Based on Physiocrine Biology
3. Family Medicine Residency Programs Recognized for Improving Childhood and Adult Immunizations Rates in Underserved Communities
4. Bureau of Prescription Health Gives the Whole Truth (and Nothing But) About Free Medicine at FreeMedicine.com
5. Medco Partners With MolecularMD on Personalized Medicine Program for Chronic Myeloid Leukemia
6. The Institute for Specialized Medicine Launches GLUTEN-FREE REMEDIES, a New Line of Gluten-free Food Supplements and Herbs.
7. Caliper Owners Group Meeting Showcases Transformative Technologies for Advancing Personalized Medicine
8. BioLife Solutions Announces Expanded Customer Base in the High Growth Regenerative Medicine Market
9. Consortium Opens Landmark Personalized Medicine Childrens Cancer Trial
10. Savient Pharmaceuticals Marketing Authorization Application for KRYSTEXXA® Accepted for Review by European Medicines Agency
11. Johnson & Johnson Highlights Strategies for Growth Through Differentiated Medicines, Transformational Pipeline and Global Product Launches
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... June 24, 2016   Pulmatrix, Inc ., (NASDAQ: ... innovative inhaled drugs, announced today that it was added ... reconstituted its comprehensive set of U.S. and global ... is an important milestone for Pulmatrix," said Chief Executive ... awareness of our progress in developing drugs for crucial ...
(Date:6/23/2016)... -- Any dentist who has made an implant supported denture ... of them do not even offer this as a viable ... costs involved. And those who ARE able to offer that ... cost that the majority of today,s patients would not be ... , founder of Dental Evolutions Inc. and inventor of Implanova ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on ... today announced that patient enrollment in its ongoing ... Duchenne) has exceeded 50% of its 24-patient target. ... in the third quarter of 2016, and to ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... ... Pixel Film Studios Released ProSlice Levels, a Media Slicing Effect Plugin ... whole new perspective by using the title layers in ProSlice Levels to split-up ... Levels contains over 30 Different presets to choose from. FCPX users can ...
(Date:6/25/2016)... Austin, TX (PRWEB) , ... June 25, 2016 , ... ... Fellow of the American College of Mohs Surgery and to Dr. Russell Peckham for ... popular and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as ... City area —Johnson is one of the first doctors to perform the treatment. ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
(Date:6/24/2016)... Diego, CA (PRWEB) , ... June 24, 2016 , ... ... with the American Cancer Society and the Road To Recovery® program to drive cancer ... to seniors and other adults to ensure the highest quality of life and ongoing ...
Breaking Medicine News(10 mins):